rss
Thorax 2000;55:143-146 doi:10.1136/thorax.55.2.143
  • Original article

Adult familial cryptogenic fibrosing alveolitis in the United Kingdom

  1. Richard P Marshalla,
  2. Anna Puddicombea,
  3. William O C Cooksonb,
  4. Geoffrey J Laurenta
  1. aCentre for Cardiopulmonary Biochemistry and Respiratory Medicine, University College London Medical School, Rayne Institute, London WC1E 6JJ, UK, bAsthma Genetics Group, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK
  1. Dr R P Marshall
  • Received 2 June 1999
  • Revision requested 22 July 1999
  • Revised 6 September 1999
  • Accepted 11 October 1999

Abstract

BACKGROUND Familial cases of cryptogenic fibrosing alveolitis (CFA) have previously been reported; however, the prevalence and genetic background of this disorder are not known. The clinical and epidemiological findings of 25 families identified within the UK are reported.

METHODS Adult pulmonary physicians in the UK were asked to identify all families under their care in which two or more individuals had been diagnosed with fibrosing alveolitis of unknown cause. A detailed structured questionnaire was sent to each proband to delineate possible environmental/occupational exposures and to obtain complete pedigree data. Physicians were also asked to provide clinical and diagnostic information.

RESULTS Twenty five families were identified comprising 67 cases. Suitable data for analysis were available for 21 families (57 cases). The male:female ratio was 1.75:1 (p<0.05). A high resolution computed tomographic (HRCT) scan was performed in 93% and a diagnosis of CFA confirmed on biopsy specimens in 32%. The mean age at diagnosis was 55.5 (2.5) years. Fifty percent of cases were ever smokers and 18% had been diagnosed as asthmatic. Exposure to known fibrogenic agents was recorded by 36% of patients. Clinical signs/symptoms and histological findings were indistinguishable from non-familial cases.

CONCLUSIONS This study represents the largest cohort of familial CFA cases reported to date and confirms a prevalence of 1.34 cases per 106 in the UK population. Although rare, such cases represent an important subgroup in which a genetic susceptibility to pulmonary fibrosis is particularly evident. Familial patients are younger at diagnosis but otherwise indistinguishable from non-familial cases. The mode of inheritance is as yet unclear but a number of genetic loci are likely to be involved and are the subject of ongoing studies.

Footnotes

  • This work was supported by the Wellcome Trust.

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.